Last reviewed · How we verify
Hypertensive urgency
Approved treatments
- Diuril · Salix Pharms
- Corlopam · Pfizer
- Cozaar · Merck & Co.
Cozaar works by blocking the action of angiotensin II on its receptor, which helps to relax blood vessels and lower blood pressure. - Microzide · Generic (originally Merck)
Lisinopril inhibits ACE, reducing angiotensin II and aldosterone, leading to lower blood pressure. - Cozaar · Merck & Co.
Losartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively binding to the AT1 receptor. - Proglycem
Proglycem works by blocking the ATP-sensitive potassium channel, which helps to increase blood sugar levels and reduce insulin secretion. - Sodium Nitroprusside · Roche
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Hypertensive urgency patent landscape — cliff calendar, originator estates, attackable patents
- Hypertensive urgency treatment landscape brief
- Hypertensive urgency treatment updates RSS
Frequently asked questions about Hypertensive urgency
What drugs treat Hypertensive urgency?
Tracked treatments include Diuril, Corlopam, Cozaar, Microzide, Proglycem, Sodium Nitroprusside.
What is the treatment for Hypertensive urgency?
Standard treatment for Hypertensive urgency includes Diuril, Corlopam, Cozaar, Microzide, Proglycem. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Hypertensive urgency patent cliff · Hypertensive urgency CI report
- Treatment: Diuril · Salix Pharms
- Treatment: Corlopam · Pfizer
- Treatment: Cozaar · Merck & Co.
- Treatment: Microzide · Generic (originally Merck)
- Treatment: Cozaar · Merck & Co.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing